IND Swift Limited Bisacodyl Export Data — India (DGFT 2022–2026)

Name: IND Swift Limited Bisacodyl Export Records India — #2 Exporter, 26 Shipments, $760.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Bisacodyl

India Pharmaceutical Trade Intelligence

$8.6M240 Suppliers108 CountriesHS 30049099

ExportsIndia → UNITED KINGDOM48.4%India → UNITED STATES9.9%

ImportsGERMANY → India$362 JAPAN → India$169

IND Swift Limited — Bisacodyl Exporter #2 | $1.1M Trade Value | TransData Nexus | TransData Nexus

IND Swift Limited — Bisacodyl Exporter Profile

Indian Pharmaceutical Exporter · #2 for Bisacodyl · $1.1M export value · DGFT Verified

IND Swift Limited is the #2 Indian exporter of Bisacodyl with $1.1M in export value and 26 verified shipments. IND Swift Limited holds a 8.8% market share in Bisacodyl exports across 1 countries. The company exports 13 pharmaceutical products worth $36.7M across 9 therapeutic categories.

IND Swift Limited — Bisacodyl Export Profile: Buyers & Destinations

IND Swift Limited Bisacodyl export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Bisacodyl?

Country	Value	Shipments	Share
UNITED KINGDOM	$4.2M	162	55.4%
UNITED STATES	$856.6K	62	11.4%
SRI LANKA	$409.0K	49	5.4%
SOUTH AFRICA	$317.8K	37

Who Are the Top Buyers of Bisacodyl from India?

Buyer	Country	Value	Orders
MOVIANTO UK LTD	UNITED KINGDOM	$1.8M	73
MOVIANTO UK LIMITED	UNITED KINGDOM	$815.4K	30
GENESIS PHARMACEUTICALS LTD	UNITED KINGDOM	$630.8K	24
MOVIANTO UK LTD,	UNITED KINGDOM	$284.9K	10
GENESIS PHARMACEUTICALS LTD.	UNITED KINGDOM	$242.4K	5
GENESIS PHARMACEUTICALS LIMITED	UNITED KINGDOM	$203.4K	5
M S GERICARE PHARMACEUTICALS	UNITED STATES	$194.1K	4
SUBSTIPHARM	FRANCE	$148.5K	5
ADCOCK INGRAM LIMITED	SOUTH AFRICA	$135.2K	16
HEMAS PHARMACEUTICALS (PVT) LTD	SRI LANKA	$122.6K	15

India's Bisacodyl is purchased by 415 buyers worldwide. The top buyer is MOVIANTO UK LTD (UNITED KINGDOM), followed by MOVIANTO UK LIMITED and GENESIS PHARMACEUTICALS LTD.

How Does IND Swift Limited Compare to Nearest Bisacodyl Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DR.REDDY'S LABORATORIES LTD	$2.0M	78	1	$25.4K
2	IND SWIFT LIMITED ★	$760.7K	26	1	$29.3K
3	BLISS GVS PHARMA LIMITED	$712.9K	26	3	$27.4K
4	DR REDDYS LABORATORIES LIMITED	$458.7K	12	1	$38.2K

IND Swift Limited ranks #2 among 240 Indian Bisacodyl exporters. Average shipment value of $29.3K compared to the market average of $26.5K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and BLISS GVS PHARMA LIMITED.

Which Indian Ports Ship Bisacodyl Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	168	13.0%
NHAVA SHEVA SEA (INNSA1)	159	12.3%
SAHAR AIR	152	11.7%
JNPT/ NHAVA SHEVA SEA	74	5.7%
HYDERABAD ICD	60	4.6%
JNPT	58	4.5%
Bombay Air	42	3.2%
AHEMDABAD ICD	32	2.5%

Geopolitical & Trade Policy Impact on IND Swift Limited's Bisacodyl Exports

Ind-Swift Laboratories' export operations have been influenced by recent geopolitical developments. The Israel-Iran conflict has heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the company's logistics and cost structures. (livemint.com)

Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded in January 2026, is poised to benefit Indian pharmaceutical exporters. The agreement eliminates tariffs on most European pharmaceutical imports, enhancing the competitiveness of Indian products in the EU market. This development presents an opportunity for Ind-Swift Laboratories to expand its footprint in Europe. (en.wikipedia.org)

In the United States, the reshoring of pharmaceutical manufacturing and potential imposition of tariffs on imports pose challenges for Indian exporters. While there are currently no import duties on Indian pharmaceutical products entering the US, the introduction of tariffs could affect the profitability of low-margin generic drugs, potentially leading to market exits. (cfo.economictimes.indiatimes.com)

IND Swift Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Indian pharmaceutical exporters. Ind-Swift Laboratories has demonstrated a commitment to quality by adhering to Good Manufacturing Practices (GMP) as stipulated by the US FDA, WHO, and EU authorities. The company's manufacturing facilities in Punjab and Jammu have been inspected and approved by these regulatory bodies, facilitating access to regulated markets.

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous investment in quality systems and supply chain transparency. Ind-Swift Laboratories' focus on high-margin formulations underscores the importance of maintaining stringent quality standards to meet global regulatory requirements and sustain market access.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Bisacodyl shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: IND Swift Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 108+ countries, 415+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Bisacodyl

Bisacodyl

IND Swift Limited — Bisacodyl Exporter Profile

IND Swift Limited — Bisacodyl Export Profile: Buyers & Destinations

Where Does India Export Bisacodyl?

Who Are the Top Buyers of Bisacodyl from India?

What Is India's Total Bisacodyl Export Value and How Much Does IND Swift Limited Contribute?

What Is the Average Shipment Value for IND Swift Limited's Bisacodyl Exports?

How Does IND Swift Limited Compare to Other Indian Bisacodyl Exporters?

Regulatory Requirements: Exporting Bisacodyl to Key Markets

United Kingdom — MHRA

United States — FDA

How Does IND Swift Limited Compare to Nearest Bisacodyl Exporters?

Which Indian Ports Ship Bisacodyl Exports?

What Other Gastrointestinal Products Does IND Swift Limited Export?

Geopolitical & Trade Policy Impact on IND Swift Limited's Bisacodyl Exports

IND Swift Limited — Regulatory Compliance & Quality Standards

About IND Swift Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Bisacodyl Export Data from IND Swift Limited

Bisacodyl Stats

Company Overview

Top Products by IND Swift Limited

Related Analysis

Need Detailed Export Data?

Data Source